pyrazolanthrone has been researched along with anisomycin in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (50.00) | 29.6817 |
2010's | 10 (41.67) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Bruchas, MR; Chavkin, C; Defino, M; Kwan, SC; Li, S; Schreiber, S; Yang, T | 1 |
Dickinson, DA; Forman, HJ; Iles, KE; Iwamoto, T; Watanabe, N | 1 |
Brown, JH; Gong, X; Lerner, DL; Petrich, BG; Saffitz, JE; Wang, X; Wang, Y | 1 |
Genade, S; Hattingh, S; Huisamen, B; Lochner, A; Marais, E; Moolman, JA | 1 |
Greene, SM; Headley, VV; Port, JD; Tanveer, R; Zweifach, A | 1 |
Fulmer, M; Harbrecht, BG; Perpetua, M; Zhang, B | 1 |
Chang, NS; Heath, J; Hsu, LJ; Jambal, P; Pugazhenthi, S; Schultz, L; Su, M; Sze, CI | 1 |
Muresan, V; Muresan, Z | 1 |
Cherla, RP; Lee, SY; Mees, PL; Tesh, VL | 1 |
Ciani, L; Salinas, PC | 1 |
Cohick, WS; Leibowitz, BJ | 1 |
Croons, V; De Meyer, GR; Herman, AG; Martinet, W; Timmermans, JP | 1 |
Du, X; Geng, W; Lin, N; Shan, Y; Wang, S; Wang, X; Zhao, R | 1 |
Aronheim, A; Koren, L; Weidenfeld-Baranboim, K | 1 |
Ai, X; Beyer, EC; Fast, VG; Kong, W; Walcott, G; Yan, J; Zhang, Q | 1 |
Muthusamy, V; Piva, TJ | 1 |
Fang, W; Jiang, J; Liu, F; Liu, Y | 1 |
Anan, H; Iida, H; Inai, T; Kitagawa, N; Minakami, M | 1 |
Kim, HJ; Kim, HM; Lee, G | 1 |
Calses, PC; Chi, Y; Clurman, BE; Dhillon, KK; Gafken, PR; Huang, JW; Jacquemont, C; Kawasumi, M; Nghiem, P; Saijo, M; Sugasawa, K; Taniguchi, T; Tucker, N; Wang, Y | 1 |
Dey, CS; Mukhopadhyay, AG; Reddy, GS | 1 |
Darwazeh, R; Deng, H; Li, TZ; Liu, Q; Xia, YZ; Yan, Y | 1 |
Baron, A; Diochot, S; Lingueglia, E; Verkest, C | 1 |
Gu, L; He, X; Hu, G; Huang, H; Li, S; Liu, X; Ma, R; Meng, J; Peng, Y; Peng, Z; Tang, J; Tao, L; Xie, Y; Yang, H; Yang, X; Zhang, Y | 1 |
24 other study(ies) available for pyrazolanthrone and anisomycin
Article | Year |
---|---|
Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Anthracenes; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Kinetics; Mice; Mice, Knockout; Models, Biological; Phosphorylation; Receptors, Opioid, kappa; Signal Transduction | 2007 |
Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase.
Topics: Anisomycin; Anthracenes; Apoptosis; Caspase 9; Caspases; Cytochrome c Group; Dactinomycin; Dose-Response Relationship, Drug; Emetine; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Mitochondria; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; Protein Biosynthesis; Protein Synthesis Inhibitors; Proteins; Time Factors | 2002 |
c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes.
Topics: Animals; Animals, Genetically Modified; Anisomycin; Anthracenes; Cell Communication; Cell Death; Cells, Cultured; Connexin 43; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Gap Junctions; Gene Targeting; Heart Failure; Heart Ventricles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Myocardium; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2002 |
Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
Topics: Animals; Anisomycin; Anthracenes; Cardiac Output; Coronary Circulation; Disease Models, Animal; Enzyme Activation; Heart Rate; Imidazoles; Ischemic Preconditioning, Myocardial; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar | 2003 |
Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition.
Topics: 3' Untranslated Regions; Animals; Anisomycin; Anthracenes; Butadienes; Cell Line; Cricetinae; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heterogeneous-Nuclear Ribonucleoproteins; Imidazoles; Mitogen-Activated Protein Kinase Kinases; Nitriles; Nucleic Acid Synthesis Inhibitors; Phosphatidylinositol 3-Kinases; Pyridines; Receptors, Adrenergic, beta; RNA Stability; Signal Transduction | 2004 |
JNK signaling involved in the effects of cyclic AMP on IL-1beta plus IFNgamma-induced inducible nitric oxide synthase expression in hepatocytes.
Topics: Animals; Anisomycin; Anthracenes; Blotting, Western; Cell Nucleus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hepatocytes; Humans; Interferon-gamma; Interleukin-1; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nucleic Acid Synthesis Inhibitors; Plasmids; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Transfection | 2004 |
Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anisomycin; Anthracenes; Brain; Cell Line; Cell Line, Tumor; COS Cells; Down-Regulation; Enzyme Inhibitors; Estradiol; Flavonoids; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Neurons; Oxidoreductases; Phosphorylation; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Retroviridae; RNA, Small Interfering; Serine; tau Proteins; Temperature; Threonine; Time Factors; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; WW Domain-Containing Oxidoreductase | 2004 |
c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein.
Topics: Adaptor Proteins, Signal Transducing; Amyloid beta-Protein Precursor; Animals; Anisomycin; Anthracenes; Blotting, Western; Cell Line; Chlorocebus aethiops; Enzyme Inhibitors; Gene Expression Regulation; Growth Inhibitors; Humans; Immunohistochemistry; Immunoprecipitation; Mice; Mitogen-Activated Protein Kinase 10; Models, Biological; Neurites; Neurons; Phosphorylation; Protein Binding; Purines; RNA, Small Interfering; Roscovitine; Transfection | 2005 |
Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line.
Topics: Aniline Compounds; Anisomycin; Anthracenes; Cell Line, Tumor; Cytokines; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-4E; Flavonoids; Humans; Imidazoles; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Purines; Pyridines; RNA, Messenger; Shiga Toxin 1; Time Factors | 2006 |
c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate Dishevelled-mediated microtubule stability.
Topics: Adaptor Proteins, Signal Transducing; Animals; Animals, Newborn; Anisomycin; Anthracenes; Bucladesine; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Cerebellum; Dishevelled Proteins; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; JNK Mitogen-Activated Protein Kinases; Mice; Microtubules; Neuroblastoma; Neurons; Nocodazole; Phosphoproteins; Time Factors; Transfection; Wnt Proteins | 2007 |
Endogenous IGFBP-3 is required for both growth factor-stimulated cell proliferation and cytokine-induced apoptosis in mammary epithelial cells.
Topics: Animals; Anisomycin; Anthracenes; Apoptosis; Cattle; Cell Line; Cell Proliferation; DNA Replication; Enzyme Activation; Epithelial Cells; Female; Imidazoles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; JNK Mitogen-Activated Protein Kinases; Mammary Glands, Animal; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2009 |
The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
Topics: Animals; Anisomycin; Anthracenes; Aorta; Apoptosis; Butadienes; Carotid Arteries; Carotid Stenosis; Cell Line, Tumor; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Imidazoles; Macrophages; Macrophages, Alveolar; Mice; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rabbits; Tunica Intima; Tunica Media | 2009 |
Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage.
Topics: Anisomycin; Anthracenes; Anticarcinogenic Agents; Blotting, Western; Cell Line; Cyclooxygenase 2; Drug Antagonism; Endothelium, Vascular; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Imidazoles; Isothiocyanates; Lipopolysaccharides; Membrane Proteins; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Nitric Oxide Synthase Type II; Phosphorylation; Pyridines; Sulfoxides; Thiocyanates; Vasculitis | 2010 |
Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation.
Topics: Animals; Anisomycin; Anthracenes; HEK293 Cells; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; NIH 3T3 Cells; Phosphorylation; Proteasome Endopeptidase Complex; Repressor Proteins; Serum; Threonine | 2011 |
c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias.
Topics: Aging; Animals; Anisomycin; Anthracenes; Arrhythmias, Cardiac; Atrial Fibrillation; Cell Communication; Cells, Cultured; Connexin 43; Disease Models, Animal; Enzyme Inhibitors; Heart Atria; Heart Conduction System; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; Rabbits | 2013 |
UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPK.
Topics: Anisomycin; Anthracenes; Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Interleukin-1alpha; MAP Kinase Signaling System; Melanocytes; Melanoma; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Sulfasalazine; Tumor Necrosis Factor-alpha | 2013 |
Sperm‑associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.
Topics: Adaptor Proteins, Signal Transducing; Anisomycin; Anthracenes; Astrocytoma; Cell Line, Tumor; Cell Movement; Humans; JNK Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Sialoglycoproteins; Up-Regulation | 2014 |
p38 Mitogen-activated protein kinase and c-Jun NH2-terminal protein kinase regulate the accumulation of a tight junction protein, ZO-1, in cell-cell contacts in HaCaT cells.
Topics: Anisomycin; Anthracenes; Cell Communication; Cell Line; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Keratinocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Zonula Occludens-1 Protein | 2015 |
RhoA-JNK Regulates the E-Cadherin Junctions of Human Gingival Epithelial Cells.
Topics: Animals; Anisomycin; Anthracenes; Cadherins; Cell Adhesion; Cell Culture Techniques; Cell Line; Culture Media; Enzyme Activation; Epithelial Attachment; Epithelial Cells; Fibronectins; Gingiva; Humans; Intercellular Junctions; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Protein Synthesis Inhibitors; rhoA GTP-Binding Protein | 2016 |
DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing.
Topics: Animals; Anisomycin; Anthracenes; DNA; DNA Damage; DNA Repair; HCT116 Cells; HeLa Cells; Humans; MAP Kinase Kinase 4; Mice; MicroRNAs; Phosphorylation; Ribonuclease III; RNA Polymerase II; RNA-Binding Proteins; Ultraviolet Rays | 2017 |
The p38 MAP kinase inhibitor, PD 169316, inhibits flagellar motility in Leishmania donovani.
Topics: Animals; Anisomycin; Anthracenes; Flagella; Flavonoids; Imidazoles; Leishmania donovani; MAP Kinase Signaling System; Microscopy, Video; Movement; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protozoan Proteins | 2017 |
Protease-activated receptor-2 regulates glial scar formation via JNK signaling.
Topics: Animals; Anisomycin; Anthracenes; Cicatrix; Female; MAP Kinase Signaling System; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Spinal Cord Injuries | 2019 |
C-Jun N-Terminal Kinase Post-Translational Regulation of Pain-Related Acid-Sensing Ion Channels 1b and 3.
Topics: Acid Sensing Ion Channels; Amino Acid Sequence; Animals; Anisomycin; Anthracenes; Cells, Cultured; Ganglia, Spinal; HEK293 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Pain; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Wistar | 2021 |
Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway.
Topics: Acetaminophen; Animals; Anisomycin; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure, Acute; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Necrosis; Pyridones; Reactive Oxygen Species | 2023 |